| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,063 | 1,190 | 1,172 | 10,258 | | Cost of Revenue | (315) | 315 | (1,287) | 509 | | | Gross Profit | 1,378 | 875 | 2,459 | 9,749 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 980 | 409 | 2,989 | 252 | | Non Recurring |
-
|
-
| (253) |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 397 | 466 | (276) | 9,497 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 28,860 | 10,249 | (60,841) | (56,374) | | Earnings Before Interest And Taxes | 397 | 466 | (276) | 9,497 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 397 | 466 | (276) | 9,497 | | Income Tax Expense | 35 | 22 | 26 | 26 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,887) | 10,694 | (61,144) | (46,903) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 29,221 | 10,694 | (61,144) | (46,903) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $29,221 | $10,694 | ($61,144) | ($46,903) |
|
0.02% Nasdaq 0.00%
Income Statement
